The 2019 Novel Coronavirus (2019-nCoV), discovered through viral pneumonia cases in Wuhan in 2019, was officially named by the World Health Organization (WHO) on January 12, 2020. Coronaviruses constitute a large family of viruses known to cause illnesses ranging from common colds to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The novel coronavirus represents a new strain previously unidentified in humans.
On January 21, 2020, the National Health Commission issued Announcement No. 1, classifying pneumonia caused by the novel coronavirus as a Category B infectious disease under the Law of the People's Republic of China on the Prevention and Treatment of Infectious Diseases, while implementing preventive and control measures typically applied to Category A infectious diseases. After eighteen months since the initial large-scale outbreak, the Chinese government has accumulated substantial experience in epidemic prevention. However, the pandemic persists, with ongoing efforts to combat the virus across China and globally. During the early stages of detection, China rapidly isolated the novel coronavirus, completed whole-genome sequencing, developed nucleic acid detection kits, and received WHO recognition for its sequencing speed. Although no specific treatment exists for COVID-19, many symptoms can be managed through clinical interventions, and vaccine/therapeutic development remains under intensive research.
The CnOpenData platform has organized standardized data related to COVID-19 prevention, encompassing global standards for medical protective products (医用防护产品), infectious disease testing (传染病检验检测), and medical infrastructure (医用基础设施). This database provides standardized information support for pandemic-related research, treatment, and protection efforts, aiming to optimize resource utilization and enhance scientific prevention/medical interventions.
To support medical research and public health initiatives, CnOpenData has opened access to COVID-19 prevention standard data for scholars and the public (contact customer service for access). We remain committed to advancing the global fight against the pandemic.
Field Specifications
Data Structure
Sample Data
Complete List of Medical Protective Products
Complete List of Medical Infrastructure
Port Health Quarantine Records
Data Update Frequency
Annual Update